Epidemiology, risk factors and treatments for antibiotic-associated diarrhea - PubMed (original) (raw)
Review
. 1998 Sep-Oct;16(5):292-307.
doi: 10.1159/000016879.
Affiliations
- PMID: 9892789
- DOI: 10.1159/000016879
Review
Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
L V McFarland. Dig Dis. 1998 Sep-Oct.
Abstract
Antibiotic-associated diarrhea (AAD) is a common complication of antibiotics and recent findings on the epidemiology, etiologies and treatment strategies are reviewed. Rates of AAD vary from 5 to 39% depending upon the specific type of antibiotic. The severity of AAD may include uncomplicated diarrhea, colitis or pseudomembranous colitis. The pathogenesis of AAD may be mediated through the disruption of the normal flora and overgrowth of pathogens or through metabolic imbalances. The impact of AAD is reflected by increased hospital stays, higher medical costs and increased rates of comorbidity. The key to decreasing these consequences is prompt diagnosis followed by effective treatment and institution of control measures.
Similar articles
- Antibiotic-associated diarrhea: epidemiology, trends and treatment.
McFarland LV. McFarland LV. Future Microbiol. 2008 Oct;3(5):563-78. doi: 10.2217/17460913.3.5.563. Future Microbiol. 2008. PMID: 18811240 Review. - [Risk factor for antibiotic-associated diarrhea. A review of the literature].
McFarland LV. McFarland LV. Ann Med Interne (Paris). 1998 Sep;149(5):261-6. Ann Med Interne (Paris). 1998. PMID: 9791558 Review. French. - [Epidemiology of Clostridium difficile infection].
Szczesny A, Martirosian G. Szczesny A, et al. Przegl Epidemiol. 2002;56(1):49-56. Przegl Epidemiol. 2002. PMID: 12150067 Review. Polish. - [Antibiotic-associated diarrhea].
Schröder O, Gerhard R, Stein J. Schröder O, et al. Z Gastroenterol. 2006 Feb;44(2):193-204. doi: 10.1055/s-2005-858978. Z Gastroenterol. 2006. PMID: 16456762 Review. German. - Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
Surawicz CM. Surawicz CM. Chemotherapy. 2005;51 Suppl 1:81-9. doi: 10.1159/000081993. Chemotherapy. 2005. PMID: 15855751 Review.
Cited by
- A Comparison of Outcomes from Antibiotic Treatment with and without Probiotics in 897 Patients with Lower Urogenital Tract Infections, Including Cystitis, Urethritis, Prostatitis, and Vulvovaginitis.
Mula D, Dervishi R, Hoxha R, Dervishi L, Gashi MM, Muçaj S, Muçaj E, Kuçi L. Mula D, et al. Med Sci Monit Basic Res. 2024 Jun 26;30:e943939. doi: 10.12659/MSMBR.943939. Med Sci Monit Basic Res. 2024. PMID: 38918937 Free PMC article. - Antibiotics Not Associated with Shorter Duration or Reduced Severity of Acute Lower Respiratory Tract Infection.
Merenstein DJ, Barrett B, Ebell MH. Merenstein DJ, et al. J Gen Intern Med. 2024 Aug;39(10):1887-1894. doi: 10.1007/s11606-024-08758-y. Epub 2024 Apr 15. J Gen Intern Med. 2024. PMID: 38619737 - Biotics and Children's and Adolescents' Health: A Narrative Review.
Xenopoulou E, Kontele I, Sergentanis TN, Grammatikopoulou MG, Tzoutzou M, Kotrokois K, Tsitsika AΚ, Vassilakou T. Xenopoulou E, et al. Children (Basel). 2024 Mar 9;11(3):329. doi: 10.3390/children11030329. Children (Basel). 2024. PMID: 38539364 Free PMC article. Review. - Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Waitzberg D, Guarner F, Hojsak I, Ianiro G, Polk DB, Sokol H. Waitzberg D, et al. Adv Ther. 2024 Mar;41(3):901-914. doi: 10.1007/s12325-024-02783-3. Epub 2024 Jan 30. Adv Ther. 2024. PMID: 38286962 Free PMC article. - Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice.
Liu P, Zhang Y, Zhang Z, Huang X, Su X, Yang S, Xie Y. Liu P, et al. Genes (Basel). 2023 Jul 10;14(7):1423. doi: 10.3390/genes14071423. Genes (Basel). 2023. PMID: 37510327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical